Category:

Non-Life

Latest

A ‘mission of the century’ as airlines prep for gargantuan vaccine supply

This will be the largest and most complex logistical exercise ever,” said Alexandre de Juniac, chief executive officer of the International Air Transport Association, the industry’s chief lobby. “The world is counting on us.”

IATA estimates that the equivalent of 8,000 loads in a 110-ton capacity Boeing 747 freighter will be needed for the airlift, which will take two years to supply some 14 billion doses, or almost two for every man, woman and child on Earth. It’s a tall order, given about one-third of the global passenger fleet is still in storage, based on data from Cirium.

read more

AXA to sell its Gulf business to GIG for $269 mn

“This transaction marks another step in AXA’s continued simplification journey. We are convinced that AXA’s operations in the Gulf region will benefit from GIG’s leadership and scale in the region, to further pursue their focus on delivering growth and excellent customer service. I would like to thank the management teams and all the employees of our operations in the Gulf region for their continuous contribution and engagement over the years, and wish them all the success for the future, said Thomas Buberl, CEO, Axa.

read more

Centre to vaccinate around 300 mn by July-August: Harsh Vardhan

The Union Minister highlighted that India has one of the highest recovery rates in the whole world. “From 1 lab in January 2020, we now have 2,165 labs. More than a million people are being tested on a daily basis. We have completed 14 crore cumulative tests today. This all shows the determination of the government and relentless efforts of our corona warriors whose contribution is significant in fighting the pandemic,” he said.

read more

Moderna to ask US, European regulators to OK its vaccine for emergency use

Moderna created its shots with the U.S. National Institutes of Health and already had a hint they were working, but said it got the final needed results over the weekend that suggest the vaccine is more than 94% effective.
Moderna is just behind Pfizer and its German partner BioNTech in seeking to begin vaccinations in the U.S. in December. Across the Atlantic, British regulators also are assessing the Pfizer shot and another from AstraZeneca.

read more

Swiss Re to set up new fund for institutional and designated investors to access Nat Cat biz

Martin Bisping, CEO of Swiss Re Insurance-Linked Investment Management  said: “This new fund will open a unique opportunity for investors to invest in the same book of business as Swiss Re, benefitting from Swiss Re’s global reach, client access, risk knowledge and underwriting.“

read more